JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure

Ōno, Minoru; Yamaguchi, Osamu; Ohtani, Tomohito; Kinugawa, Koichiro; Saiki, Yoshikatsu; Sawa, Yoshiki; Shiose, Akira; Tsutsui, Hiroyuki; Fukushima, Norihide; Matsumiya, Goro; Yamazaki, Kenji; Yamamoto, Kazuhide; Akiyama, Mitoshi; Imamura, Teruhiko; Iwasaki, Kiyotaka; Endo, Miyoko; Ohnishi, Yoshihiko; Okumura, Takahiro; Kashiwa, Koichi; Katoh, Osamu; Kubota, Kaori; Seguchi, Osamu; Toda, Köichi; Nishioka, Hiroshi; Nishinaka, Tomohiro; Nishimura, Takashi; Hashimoto, Toru; Hatano, Masaru; Higashi, Haruhiko; Higo, Taiki; Fujino, Takeo; Hori, Yumiko; Miyoshi, Toru; Yamanaka, Motoharu; Ohno, Takayuki; Kimura, Takeshi; Kyo, Shunei; Sakata, Yasushi; Nakatani, Takeshi

doi:10.1253/circj.cj-21-0880

Cited by 12 publications

(8 citation statements)

References 282 publications

(245 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After the discharge, a multidisciplinary LVAD team including VAD nurses provided the patients with self-care support regularly. The contents of education were decided according to the national and international guidelines about LVAD management [9,31,32].…”

Section: Discussionmentioning

confidence: 99%

“…All estimates of skewness were negative and ranged from -0.54 (item 24) to -7.53 (item 33), indicating a tail to the left for all items; kurtosis ranged from -0.97 (item 21) to 60.67 (item 33). Several items demonstrated low item-total correlation (Pearson's r <0.2) (items 10,11,14,29,31,33), indicating that these items have a weak relationship to other items [28]. All other items had satisfactory item-total correlation ranging between 0.20 and 0.54.…”

Section: Descriptive Statistics Of the Self-care Scale Itemsmentioning

confidence: 99%

See 1 more Smart Citation

Validity and reliability of the left ventricular assist device self-care behaviour scale

et al. 2023

View full text Add to dashboard Cite

Background Adequate self-care behaviour is essential for patients with a left ventricular assist device (LVAD) to prevent complications, prolong life, and optimise quality of life. However, there were no valid and reliable measurements available to assess self-care behaviour among patients with LVAD. We have previously developed the 33-item LVAD self-care behaviour scale. Objectives To evaluate psychometric properties of the 33-item LVAD self-care behaviour scale. Methods and results Data on 127 patients with a LVAD in Israel, Japan, and the USA were analysed (mean age 51±14.3, 81% male). Exploratory factor analysis extracted three factors, and 13 items were excluded from the scale. Internal consistency assessed by Cronbach’s alpha was acceptable for the total scale (α = 0.80) and the three subscales: Factor 1: Monitoring (α = 0.81), Factor 2: Heart failure self-care (α = 0.67), and Factor 3: LVAD self-care (α = 0.63). The 20-item version of the LVAD self-care behaviour scale had sufficient convergent validity with another scale that assessed self-care related to the driveline of LVAD (r = 0.47, p<0.001). Test–retest reliability was adequate (intraclass correlation coefficient = 0.58). Conclusions The 20-item version of the LVAD self-care behaviour scale showed adequate validity and reliability. The scale is ready for use in clinical practice and research. Additional testing might further optimise the scale.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Descriptive Statistics Of the Self-care Scale Itemsmentioning

confidence: 99%

Validity and reliability of the left ventricular assist device self-care behaviour scale

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In Japan, the waiting time for HTx has increased to more than 5 years due to a shortage of donors [ 7 ]. Our allocation system does not include a high-urgency system, differing from the European transplant system [ 7 , 13 ]. Thus, AR associated with cf-LVAD is an issue that requires our immediate attention.…”

Section: Discussionmentioning

confidence: 99%

“…In patients with AR inducing uncontrolled HF, surgical interventions, such as surgical aortic valve replacement (SAVR) or repair (AVP), may be secondarily selected as a bridge-to-heart transplantation (BTT), based on the local transplant allocation systems [ 6 ]. In Japan, the recent waiting time for HTx is longer than 5 years [ 7 ]. Therefore, surgical interventions for AR remain the only feasible option for overcoming this increasingly prolonged waiting period [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Surgical Interventions for Late Aortic Valve Regurgitation Associated with Continuous Flow-LeTableft Ventricular Assist Device Therapy: Experience Gained and Lessons Learned

Gyoten

Amiya

Ōno

2022

Life

Self Cite

View full text Add to dashboard Cite

This study aimed to investigate the outcomes of surgical interventions for symptomatic moderate-to-severe aortic regurgitation (AR), including aortic valve replacement (AVR) and repair (AVP), in 184 patients who underwent continuous flow-left ventricular assist device (Cf-LVAD) implantation as a bridge-to-transplant (BTT) between November 2007 and April 2020. Ten patients (median age, 34 (25–41) years; 60% men) underwent surgical interventions (AVR, n = 6; AVP, n = 4) late after cf-LVAD implantation. The median duration after the device implantation was 34 (24–44) months. Three patients required additional tricuspid valve repair. Aortic valve suturing resulted in severe recurrent AR 6 months postoperatively, due to leaflet cutting in one patient. Seven patients with AVR survived without regurgitation during the study period, except for one non-survivor complicated by liver failure due to postoperative right heart failure. Therefore, six patients after AVP (n = 4) and AVR (n = 2) underwent successful heart transplantation 7 (4–13) months after aortic intervention. Kaplan–Meier analysis showed no significant difference in overall survival through 5 years after cf-LVAD implantation, regardless of the surgical AV intervention chosen (log-rank test, p = 0.86). In conclusion, surgical interventions (AVR or AVP) for patients with an ongoing cf-LVAD are safe, effective, and viable options.

show abstract

“…A left ventricular assist device (LVAD) is essential for treating advanced heart failure, and the number of LVAD recipients has been increasing in Japan. 1 However, it is still unclear whether diabetes is harmful or harmless for the outcomes of LVAD recipients. Several studies have addressed this question in the past decade (Table ) patients with and without diabetes.…”

mentioning

confidence: 99%

Diabetes in Left Ventricular Assist Device Therapy　― Harmful or Harmless? ―

Higashi

Inaba

Yamaguchi

2022

Circ J

Self Cite

View full text Add to dashboard Cite

show abstract

JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure

Cited by 12 publications

References 282 publications

Validity and reliability of the left ventricular assist device self-care behaviour scale

Validity and reliability of the left ventricular assist device self-care behaviour scale

Surgical Interventions for Late Aortic Valve Regurgitation Associated with Continuous Flow-LeTableft Ventricular Assist Device Therapy: Experience Gained and Lessons Learned

Diabetes in Left Ventricular Assist Device Therapy　― Harmful or Harmless? ―

Contact Info

Product

Resources

About

JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure

Cited by 12 publications

References 282 publications

Validity and reliability of the left ventricular assist device self-care behaviour scale

Validity and reliability of the left ventricular assist device self-care behaviour scale

Surgical Interventions for Late Aortic Valve Regurgitation Associated with Continuous Flow-LeTableft Ventricular Assist Device Therapy: Experience Gained and Lessons Learned

Diabetes in Left Ventricular Assist Device Therapy ― Harmful or Harmless? ―

Contact Info

Product

Resources

About

Diabetes in Left Ventricular Assist Device Therapy　― Harmful or Harmless? ―